XML 30 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Deficit
12 Months Ended
Feb. 28, 2017
Stockholders' Deficit [Abstract]  
SHAREHOLDERS' EQUITY

NOTE 10 - STOCKHOLDERS’ DEFICIT

 

Common Stock

 

At February 28, 2017 and February 29, 2016, we had 150,000,000 shares of $0.0001 par value common stock authorized for issuance. During the year ended February 28, 2017 we issued 950,000 shares of common stock in settlement of a note payable in the amount of $150,000 plus accrued interest of $15,288. During the year ended February 29, 2016, we did not issue any shares of common stock.

 

Employee Stock Options

 

In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan, subject to shareholder approval, which was obtained at a special shareholders meeting in 2011. Under the Plan, the Company may grant options for up to the greater of Three Million (3,000,000) or 10% of the number of shares of the Common Stock of Aura from time to time outstanding. The exercise price of each option shall be at least equal to the fair market value of such shares on the date of grant. The term of the options may not be greater than ten years, and they typically vest over a three-year period.

 

During the year ended February 28, 2017, no employee options were granted by the Company.

 

The Company incurred stock options related expenses of $0 and $0, during the years ended February 28, 2017 and February 29, 2016, respectively.

 

Activity in this plan is as follows:

 

  2006 Plan 
  Weighted-Average Exercise Price  Aggregate Intrinsic Value  Number of Options 
          
Outstanding, February 28, 2015 $0.75-$1.00  $       0.00   7,777,000 
Granted  -       - 
Cancelled $0.75       (553,000)
Outstanding, February 29, 2016 $0.75-$1.00  $0.00   7,224,000 
Granted  -       - 
Cancelled $     0.75       - 
Outstanding, February 28, 2017 $0.75-$1.00       7,224,000 

 

The exercise prices for the options outstanding at February 28, 2017, and information relating to these options is as follows:

 

Options Outstanding  Exercisable Options 
Range of Exercise
Price
 Number  Weighted Average Remaining
Life
  Weighted Average
Exercise Price
  Weighted Average Remaining 
Life
 Number  Weighted Average
Exercise Price
 
$0.75-$1.00  7,224,000   3 years  $0.79  3 years  7,224,000  $0.79 

 

The weighted average fair values of the options on the date of grant for the year ended February 29, 2016 and February 28, 2015 were nil per share and $0.0 per share, respectively.


Warrants

 

Activity in issued and outstanding warrants is as follows:

 

  Number of Shares  Exercise Prices 
Outstanding, February 29, 2016  35,626,208  $0.10-$1.50 
Granted  -   - 
Exercised  -   - 
Expired  (9,172,187) $1.50 
Outstanding, February 28, 2017  26,454,021  $0.10-$1.00 

 

The exercise prices for the warrants outstanding at February 28, 2017, and information relating to these warrants is as follows:

 

Range of Exercise Prices  Stock Warrants Outstanding  Stock Warrants Exercisable  Weighted-
Average
Remaining Contractual Life
  Weighted-Average Exercise Price of Warrants Outstanding  Weighted-Average Exercise Price of Warrants Exercisable  Intrinsic Value 
$0.10-$0.75   18,381,012   18,381,012   49 months  $0.56  $0.56  $0.00 
$0.75   1,082,734   1,082,734   48 months  $0.75  $0.75  $0.00 
$0.75   1,000,000   1,000,000   38 months  $0.75  $0.75  $0.00 
$0.75-$1.00   5,990,275   5,990,275   33 months  $0.77  $0.77  $0.00 
     26,454,021   26,454,021